Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection

Table 4 Correlation between patomorphological (MEST) and clinical prognostic risk factors

Pair of variables	Spearman R	Entire group (N = 73) p value	Spearman R	Drug-treated (N = 39) p value
M & S-Creat	0.3	0.02	-	NS
M & eGFR	−0.3	0.03	-	NS
M & eGFR (FU)	−0.3	0.01	-	NS
M & U-Prot	0.4	0.0001	-	NS
M & U-Prot (FU)	0.3	0.04	0.3	0.04
E & MAP	0.3	NS	0.6	0.03
E & S-Creat	0.3	0.02	-	NS
E & U-Prot	0.3	0.003	-	NS
E & S-Chol	0.3	0.008	-	NS
S & eGFR	−0.3	0.02	-	NS
S & eGFR (FU)	−0.4	0.0006	−0.4	0.02
S & U-Prot	0.5	0.00004	0.5	0.0006
S & U-Prot (FU)	0.4	0.0006	0.5	0.002
T & Age	0.3	0.03	-	NS
T & S-Creat	0.4	0.002	0.6	0.0002
T & MAP (FU)	0.3	0.03	-	NS
T & eGFR	−0.4	0.0009	−0.5	0.0009
T & eGFR (FU)	−0.5	0.00004	−0.5	0.001

M mesangial hypercellularity, E endocapillary hypercellularity, S segmental glomerulosclerosis, T tubular atrophy/interstitial fibrosis, eGFR estimated glomerular filtration rate, MAP mean arterial pressure, U-Prot urinary protein excretion

ISSN: 1471-2369